Catalyst

Catalyst Awardees Apply CRISPR-mediated Activation to Obesity

Researchers Nadav and Navneet
Left to right: Nadav Ahituv, PhD, professor of Bioengineering and Navneet Mattharu, PhD, assistant researcher  
January 16, 2019

Catalyst Program Awardee Executes World’s First In Utero Blood Stem Cell Therapy Clinical trial

Tippi MacKenzie (left), MD, of UCSF Benioff Children’s Hospital San Francisco, visits with newborn Elianna, who received a stem cell transplant before birth
Tippi MacKenzie (left), MD, of UCSF Benioff Children’s Hospital San Francisco, visits with newborn Elianna, who received a stem cell transplant before birth. Photo by Barbara Ries
May 27, 2018

Accelerating Innovations: Catalyst Program Spurs UCSF Scientists and Physicians to Innovate to Help Patients

Surgeons, radiologists, oncologists and others presented their innovative solutions to problems they've encountered in their practices.
February 28, 2018

Converting Ideas to Products: Catalyst Pairs UCSF Scientists with Business to Improve Clinical Outcome for Patients

By Dan Fost

It’s great to have success, whether in science or in business, but sometimes failure is even better.

August 01, 2017

UC Launches Drug Discovery Consortium

Catherine Tralau-Stewart, UCSF

Note: The consortium brings together UC's five medical center campuses — Davis, Irvine, Los Angeles, San Diego and San Francisco — to share resources and expertise to help develop new drugs.

By Alec Rosenberg via UC Newsroom

May 16, 2017

To Get From Bench to Bedside, UCSF Scientists Get Help From Catalyst Program

By Dan Fost

To develop a new drug, or create a new diagnostic test or medical device, a scientist often needs a catalyst – something to spark the innovative idea that has the potential to change the way a disease is treated and improve patient outcomes.

April 13, 2017

Catalyst for Cures: UCSF Program Gives Hope to People with Rare Diseases

By Dan Fost

When a child is diagnosed with a rare and life-threatening disease, the parents often don’t know where to turn.

Mark Dant was told his toddler, Ryan, wouldn’t make it to his tenth birthday. Ryan had a rare genetic disorder, the doctors called it, Mucopolysaccharidosis (MPS I).

April 11, 2017

New Targeted Chemotherapy Technology Proves Effective in Mice

Compound Can be Administered at 50x Higher Doses and Effectively Shrinks Tumors with Few Side Effects in Mouse Tests
December 14, 2016

Virtually Biotechs

Why early stage academic deals are heating up

May 12, 2016

Pages